Sökresultat - Murat O. Arcasoy

Förfina resultatet
  1. 1
    The non‐haematopoietic biological effects of erythropoietin

    The non‐haematopoietic biological effects of erythropoietin av Murat O. Arcasoy

    Publicerad 2008
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  2. 2
    A Novel Role for Erythropoietin During Fibrin-Induced Wound-Healing Response

    A Novel Role for Erythropoietin During Fibrin-Induced Wound-Healing Response av Zishan A. Haroon, Khalid Amin, Xiaohong Jiang, Murat O. Arcasoy

    Publicerad 2003
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3
    Familial Erythrocytosis Associated With a Short Deletion in the Erythropoietin Receptor Gene

    Familial Erythrocytosis Associated With a Short Deletion in the Erythropoietin Receptor Gene av Murat O. Arcasoy, Barbara Degar, Kevin W. Harris, Bernard G. Forget

    Publicerad 1997
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    Mechanisms of erythropoietin‐mediated cardioprotection during ischemia‐reperfusion injury: role of protein kinase C and phosphatidylinositol 3‐kinase signaling

    Mechanisms of erythropoietin‐mediated cardioprotection during ischemia‐reperfusion injury: role of protein kinase C and phosphatidylinositol 3‐kinase signaling av Paul Hanlon, Ping Fu, Gary L. Wright, Charles Steenbergen, Murat O. Arcasoy, Elizabeth Murphy

    Publicerad 2005
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Erythropoietin Biology in Cancer

    Erythropoietin Biology in Cancer av Matthew E. Hardee, Murat O. Arcasoy, Kimberly Blackwell, John P. Kirkpatrick, Mark W. Dewhirst

    Publicerad 2006
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  6. 6
    Erythropoietin and Erythropoietin Receptor Expression in Head and Neck Cancer: Relationship to Tumor Hypoxia

    Erythropoietin and Erythropoietin Receptor Expression in Head and Neck Cancer: Relationship to Tumor Hypoxia av Murat O. Arcasoy, Khalid Amin, Shu-Chuan Chou, Zishan A. Haroon, Mahesh A. Varia, James A. Raleigh

    Publicerad 2005
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    Erythropoietin receptor contributes to melanoma cell survival in vivo

    Erythropoietin receptor contributes to melanoma cell survival in vivo av Suresh Kumar, G Zhang, Boris C. Bastian, Murat O. Arcasoy, Pankaj Karande, Anitha Pushparajan, Géza Ács, Xiaowei Xu

    Publicerad 2011
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and Progression

    Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and Progression av Matthew E. Hardee, Yiting Cao, Ping Fu, Xiaohong Jiang, Yulin Zhao, Zahid N. Rabbani, Željko Vujašković, Mark W. Dewhirst, Murat O. Arcasoy

    Publicerad 2007
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Failure of Terminal Erythroid Differentiation in EKLF-Deficient Mice Is Associated with Cell Cycle Perturbation and Reduced Expression of E2F2

    Failure of Terminal Erythroid Differentiation in EKLF-Deficient Mice Is Associated with Cell Cycle Perturbation and Reduced Expression of E2F2 av André M. Pilon, Murat O. Arcasoy, Holly K. Dressman, Serena E. Vayda, Yelena Maksimova, José Sangerman, Patrick G. Gallagher, David M. Bodine

    Publicerad 2008
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    <i>ZCCHC8</i>, the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation

    <i>ZCCHC8</i>, the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation av Dustin L. Gable, Valeriya Gaysinskaya, Christine C. Atik, C. Conover Talbot, Byunghak Kang, Susan E. Stanley, Elizabeth Pugh, Nuria Amat-Codina, Kara M. Schenk, Murat O. Arcasoy, Cory Brayton, Liliana Florea, Mary Armanios

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    Lung transplantation in telomerase mutation carriers with pulmonary fibrosis

    Lung transplantation in telomerase mutation carriers with pulmonary fibrosis av Leann Silhan, Pali D. Shah, Daniel C. Chambers, Laurie D. Snyder, Gerdt C. Riise, Christa L. Wagner, Eva Hellström-Lindberg, Jonathan B. Orens, Juliette F. Mewton, Sonye K. Danoff, Murat O. Arcasoy, Mary Armanios

    Publicerad 2014
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer

    American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer av J. Douglas Rizzo, Melissa Brouwers, Patricia A. Hurley, Jerome Seidenfeld, Murat O. Arcasoy, Jerry L. Spivak, Charles L. Bennett, Julia Bohlius, Darren M. Evanchuk, Matthew J. Goode, Ann A. Jakubowski, David H. Regan, Mark R. Somerfield

    Publicerad 2010
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  13. 13
    American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer

    American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer av J. Douglas Rizzo, Melissa Brouwers, Patricia A. Hurley, Jerome Seidenfeld, Murat O. Arcasoy, Jerry L. Spivak, C. L. Bennett, Julia Bohlius, Darren M. Evanchuk, Matthew J. Goode, Ann A. Jakubowski, David H. Regan, Mark R. Somerfield

    Publicerad 2010
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  14. 14
    ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial

    ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial av Stephen T. Oh, Moshe Talpaz, Aaron T. Gerds, Vikas Gupta, Srđan Verstovšek, Ruben A. Mesa, Carole B. Miller, Candido E. Rivera, Angela G. Fleischman, Swati Goel, Mark Heaney, Casey L. O’Connell, Murat O. Arcasoy, Yafeng Zhang, Jun Kawashima, Tomas Ganz, Mark Kowalski, Carrie Baker Brachmann

    Publicerad 2020
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    Diagnosis of Capnocytophaga canimorsus Sepsis by Whole-Genome Next-Generation Sequencing

    Diagnosis of Capnocytophaga canimorsus Sepsis by Whole-Genome Next-Generation Sequencing av Maria K. Abril, Adam S. Barnett, Kara Wegermann, Eric Fountain, Andrew D. Strand, Benjamin Heyman, Britton Blough, Aparna Swaminathan, Batu K. Sharma‐Kuinkel, Felicia Ruffin, Barbara D. Alexander, Chad M. McCall, Sylvia F. Costa, Murat O. Arcasoy, David K. Hong, Timothy A. Blauwkamp, Michael A. Kertesz, Vance G. Fowler, Bryan Kraft

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  16. 16
    Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

    Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I av Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, R. S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, E. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Azra Raza, Kris Vaddi, William Sun, Wei Peng, V. Sandor, Hagop M. Kantarjian

    Publicerad 2015
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  17. 17
    Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

    Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial av Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Mark M. Jones, Deanna Kornacki, Kang Sun, Hagop M. Kantarjian

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  18. 18
    The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo‐controlled, Phase <scp>III</scp> study in patients with myelofibrosis

    The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo‐controlled, Phase <scp>III</scp> study in patients with myelofibrosis av Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson‐Viitanen, William Sun, Victor Sandor, Hagop M. Kantarjian

    Publicerad 2013
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  19. 19
    Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors

    Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors av Mohamed Shanavas, Uday Popat, Laura C. Michaelis, Veena Fauble, Donal P. McLornan, Rebecca B. Klisovic, John Mascarenhas, Roni Tamari, Murat O. Arcasoy, James Davies, Usama Gergis, Oluchi C. Ukaegbu, Rammurti T. Kamble, John M. Storring, Navneet S. Majhail, Rizwan Romee, Srđan Verstovšek, Antonio Pagliuca, Sumithira Vasu, Brenda Ernst, Eshetu G. Atenafu, Ahmad Hanif, Richard Champlin, Parameswaran Hari, Vikas Gupta

    Publicerad 2015
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  20. 20
    Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I

    Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I av Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, E. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson‐Viitanen, William Sun, V. Sandor, H. Kantarjian

    Publicerad 2013
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: